NATIONAL ALLIANCE OF STATE AND TERRITORIAL AIDS DIRECTORSDBA NASTAD

EIN: 911568650 501(c)(3) Health Care

WASHINGTON, DC

Total Revenue
$26,523,136
Total Expenses
$25,983,603
Total Assets
$13,162,788
Net Assets
$4,526,562
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1992
Legal Domicile
DC
Principal Officer
STEPHEN LEE
Phone
2024348090
Tax Period
2022-10-01 to 2023-09-30

NATIONAL ALLIANCE OF STATE AND TERRITORIAL AIDS DIRECTORSDBA NASTAD, founded in 1992, is a mid-sized nonprofit in the Health Care sector that reported $26.5M in total revenue in fiscal year 2022. Revenue surged 47% from the prior year, signaling strong growth momentum.

Mission

NASTAD'S MISSION IS TO ADVANCE THE HEALTH AND DIGNITY OF PEOPLE LIVING WITH AND IMPACTED BY HIV/AIDS, VIRAL HEPATITIS, AND INTERSECTING EPIDEMICS BY STRENGTHENING GOVERNMENTAL PUBLIC HEALTH AND LEVERAGING COMMUNITY PARTNERSHIPS.

Program Service Accomplishments

Program 1
Expenses: $15,227,328

SYNDEMIC APPROACHESPREVENTION: NASTAD'S HIV PREVENTION AND SURVEILLANCE ACTIVITIES ARE PRIMARILY FUNDED THROUGH A CDC COOPERATIVE AGREEMENT TO CONDUCT CAPACITY BUILDING/TECHNICAL ASSISTANCE (TA)...

Read more

SYNDEMIC APPROACHESPREVENTION: NASTAD'S HIV PREVENTION AND SURVEILLANCE ACTIVITIES ARE PRIMARILY FUNDED THROUGH A CDC COOPERATIVE AGREEMENT TO CONDUCT CAPACITY BUILDING/TECHNICAL ASSISTANCE (TA) ACTIVITIES AND COMMUNICATION IN SUPPORT OF STATE AND LOCAL HIV PREVENTION PROGRAMS FUNDED FOR PHASE 1 OF ENDING THE HIV EPIDEMIC (EHE) INITIATIVE. ADDITIONALLY, NASTAD HAS RECEIVED FUNDING FROM CDC THROUGH CSTLTS TO DEVELOPMENT A LEARNING COMMUNITY REGARDING HIV CLUSTER DETECTION AND RESPONSE. ON SEPTEMBER 30, 2022, NASTAD RECEIVED FUNDING FROM CDC DHP FOR SUPPLEMENTAL FUNDS TO EXPANDED ON NASTAD'S EHE PHASE I IMPLEMENTATION ACTIVITIES. ON SEPTEMBER 30, 2022, NASTAD WAS FUNDED THROUGH A FIVE YEAR SUBAWARD FROM EMORY UNIVERSITY FOR A CDC NATIONAL HIV SELF-TESTING PROJECT CALLED TOGETHER TAKE ME HOME. VIRAL HEPATITIS: THROUGH A COOPERATIVE AGREEMENT WITH FUNDING FROM THE CDC'S DIVISION OF VIRAL HEPATITIS (THROUGH THE CSTLTS FUNDING MECHANISM) NASTAD HAS A (VIRTUAL) TECHNICAL ASSISTANCE (TA) CENTER (HEPTAC) TO SUPPORT HEALTH DEPARTMENT HEPATITIS PROGRAMS WITH THE PREVENTION, SURVEILLANCE, AND LABORATORY ACTIVITIES. THE PROGRAM INCLUDES SUPPORTING HEALTH DEPARTMENT HEPATITIS PREVENTION AND SURVEILLANCE PROGRAMS WITH TAILORED TECHNICAL ASSISTANCE AND OTHER MODALITIES INCLUDING VIRTUAL LEARNING COMMUNITIES. ADDITIONALLY, NASTAD IS FUNDED FOR ANOTHER COOPERATIVE AGREEMENT WITH CDC'S DIVISION OF VIRAL HEPATITIS: NATIONAL VIRAL HEPATITIS EDUCATION, AWARENESS, AND CAPACITY BUILDING FOR COMMUNITIES AND PROVIDERS (HEPNET). FINALLY, NASTAD'S HEPATITIS PROGRAM ALSO INCLUDES PARTICIPATION AND LEADERSHIP IN THE NATIONAL VIRAL HEPATITIS ROUNDTABLE AND PROMOTION OF FEDERAL PROGRAMS THAT ADDRESS HEPATITIS A (HAV) AND HEPATITIS B (HBV) VACCINE FOR HIGH-RISK ADULTS, PREVENTION OF HCV, CHRONIC HBV AND HCV AND HIV HCV CO INFECTION. THIS PROGRAM IS SUPPORTED BY BOTH THE MEMBERSHIP AND CORPORATE DONORS.DRUG USER HEALTH: SINCE SEPTEMBER 30, 2022, NASTAD HAS BEEN IMPLEMENTING A COOPERATIVE WITH CDC'S DVH FOR STRENGTHENING SYRINGE SERVICES PROGRAMS (SSPS) THROUGH WHICH NASTAD PROVIDES DIRECT FUNDING TO SSPS THROUGHOUT THE U.S. NASTAD HAD A COOPERATIVE WITH CDC DIVISION OF VIRAL HEPATITIS (DVH) FOR THE NATIONAL HARM REDUCTION TECHNICAL ASSISTANCE CENTER THAT ENDED JULY 31, 2023. IN ADDITION, SUPPORTING THE PROVISION OF TA TO SYRINGE SERVICES PROGRAMS (SSPS) AND OTHER HARM REDUCTION PROVIDERS, IT INCLUDED A DEMONSTRATION PROJECT THROUGH WHICH NASTAD AWARDED FUNDS TO SUPPORT SSPS WITH PROVIDING ACCESS TO MEDICATION ASSESSMENT TREATMENT AND OTHER SERVICES. NASTAD ALSO HELD COOPERATIVE AGREEMENTS WITH CDC THROUGH CSTLTS FOCUSED ON EXPANDING SSP CAPACITY TO RESPOND TO COVID 19 AND FOR AN EXPANSION OF THE OF NATIONAL HARM REDUCTION TECHNICAL ASSISTANCE CENTER TO INCLUDE COORDINATION OF SAMHSA-FUNDED TA PROVIDERS WHICH ENDED NOVEMBER 15, 2023.

Program 2
Expenses: $5,126,407 Revenue: $1,411,888

STRENGTHENING PUBLIC HEALTH SYSTEMS:HEALTH CARE ACCESS: NASTAD IS IN THE SECOND YEAR OF A FIVE-YEAR COOPERATIVE AGREEMENT WITH HEALTH RESOURCES AND SERVICES ADMINISTRATION (HRSA) TO PROVIDE TECHNICAL...

Read more

STRENGTHENING PUBLIC HEALTH SYSTEMS:HEALTH CARE ACCESS: NASTAD IS IN THE SECOND YEAR OF A FIVE-YEAR COOPERATIVE AGREEMENT WITH HEALTH RESOURCES AND SERVICES ADMINISTRATION (HRSA) TO PROVIDE TECHNICAL ASSISTANCE (TA) FOR AIDS DRUG ASSISTANCE PROGRAMS (ADAP) AND RYAN WHITE PART B PROGRAMS. PROGRAM ACTIVITIES INCLUDE A FOCUS ON ADAP CLINICAL QUALITY, AS WELL AS TA TO ADAPS ON VARIOUS ISSUES INCLUDING IMPLEMENTATION OF THE AFFORDABLE CARE ACT (ACA), INSURANCE PURCHASING, INTEGRATED PLANNING, FINANCIAL FORECASTING, IMPLEMENTING QUALITY MEASURES AND NEW DATA COLLECTION ACTIVITIES, DEVELOPING, AND DISSEMINATING VARIOUS MATERIALS, AND IMPLEMENTING AND MONITORING DRUG PRICING AGREEMENTS. NASTAD HAS AN ONGOING PROJECT SUPPORTED BY CORPORATE DONORS TO MONITOR AND ASSESS THE STATUS OF STATE ADAPS AUTHORIZED UNDER PART B OF THE RYAN WHITE PROGRAM. IN ADDITION TO PRODUCING THE NATIONAL ADAP MONITORING PROJECT ANNUAL REPORT, THE PROGRAM PROVIDES TA TO STATE ADAPS REGARDING VARIOUS PROGRAMMATIC AND FISCAL ISSUES. NASTAD ALSO CONVENES AND SUPPORTS THE WORK OF AN ADAP CRISIS TASK FORCE, MADE UP OF STATE AIDS DIRECTORS AND ADAP COORDINATORS WORKING ON BEHALF OF ALL STATE HIV/AIDS PROGRAMS TO IMPROVE THE FISCAL STATUS OF STATE ADAP PROGRAMS. THIS PROGRAM IS SUPPORTED BY NASTAD'S MEMBERSHIP. HEALTH SYSTEMS INTEGRATION: NASTAD HAS TWO COOPERATIVE AGREEMENTS WITH HEALTH RESOURCES AND SERVICES ADMINISTRATION (HRSA). ONE IS SERVICE AS THE SYSTEMS COORDINATION PROVIDER (SCP) FOR HRSA'S ENDING THE HIV EPIDEMIC (EHE) INITIATIVE. THE SECOND COOPERATIVE AGREEMENT FOR A SPECIAL PROJECTS OF NATIONAL SIGNIFICANCE (SPNS) INITIATIVE: BUILDING CAPACITY TO IMPROVE COLLECTING AND REPORTING VIRAL SUPPRESSION DATA TO THE MEDICAID ADULT CORE SET.

Program 3
Expenses: $2,528,313 Revenue: $245,192

ORGANIZATIONAL EXCELLENCE: CBA: NASTAD HAS A COOPERATIVE AGREEMENT WITH CDC'S DIVISION OF HIV PREVENTION (DHP) TO PROVIDE TECHNICAL ASSISTANCE TO HEALTH DEPARTMENTS AND CDC-DIRECTLY FUNDED...

Read more

ORGANIZATIONAL EXCELLENCE: CBA: NASTAD HAS A COOPERATIVE AGREEMENT WITH CDC'S DIVISION OF HIV PREVENTION (DHP) TO PROVIDE TECHNICAL ASSISTANCE TO HEALTH DEPARTMENTS AND CDC-DIRECTLY FUNDED COMMUNITY-BASED ORGANIZATIONS (CBOS) ON INTEGRATED HIV PREVENTION STRATEGIES. NATIONAL HIV AND HEPATITIS TECHNICAL ASSISTANCE MEETING: NASTAD CONVENES A TECHNICAL ASSISTANCE MEETING EACH YEAR FOR HIV PREVENTION, CARE INCLUDING ADAP COORDINATORS, HEPATITIS, AND DRUG USER HEALTH STAFF. IT IS SUPPORTED THROUGH CORPORATE CONTRIBUTIONS SPECIFICALLY FOR THIS PURPOSE.ANNUAL MEETING: NASTAD CONVENES AN ANNUAL MEETING OF THE GENERAL MEMBERSHIP EACH SPRING, SUPPORTED BY THE MEMBERSHIP AND CORPORATE DONORS. THIS PROGRAM INCLUDES ALL ACTIVITIES IN SUPPORT OF THE ANNUAL MEETING THAT ARE NOT DIRECTLY SUPPORTED BY OTHER PROGRAMS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2022)

Revenue Breakdown

Contributions & Grants $24,812,921
Program Service Revenue $1,657,080
Investment Income $1,512
Other Revenue $51,623
TOTAL REVENUE $26,523,136

Expense Breakdown

Grants Paid $9,251,894
Salaries & Benefits $8,538,060
Fundraising Expenses $173,563
Program Expenses $23,517,394
Other Expenses $8,193,649
TOTAL EXPENSES $25,983,603

Year-over-Year Comparison

2022 2021 Change
Revenue $26,523,136 $18,000,771 +0.5%
Expenses $25,983,603 $17,011,945 +0.5%
Net Income $539,533 $988,826 -0.5%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
22
Independent Members
22
Employees
83
Volunteers
25

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
8
$265,243
Total Directors
32
$0
Key Employees
2
$376,980
Highest Compensated
5
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
STEPHEN LEE EXECUTIVE DIRECTOR 40.00
Officer
$220,275 $44,968 $265,243
NATALIE CRAMER DEPUTY EXECUTIVE DIRECTOR, PROGRAM 40.00
Key Emp
$171,002 $23,409 $194,411
VIRGINIE CAREY DEPUTY EXECUTIVE DIRECTOR, OPERATIONS 40.00
Key Emp
$171,182 $11,387 $182,569
TIM HORN DIRECTOR, MEDICATION ACCESS 40.00
Highest
$130,552 $32,435 $162,987
EMILY SCHREIBER SR DIR, POLICY & LEGISLATIVE AFFAIRS 40.00
Highest
$139,122 $22,315 $161,437
AUNTRE HAMP SR DIR, PUBLIC HEALTH SYSTEMS 40.00
Highest
$144,240 $16,192 $160,432
ISAIAH WEBSTER III SR DIR, ORGANIZATIONAL EXCELLENCE 40.00
Highest
$137,746 $19,029 $156,775
BOATEMAA NTIRI REID SR DIR SYNDEMIC APPROACHES 40.00
Highest
$127,235 $8,790 $136,025
DAVID KERN CHAIR (FROM 6/2023) 1.50
Officer Director
$0 $0 $0
CLOVER BARNES CHAIR-ELECT (END 6/2023) 1.50
Officer Director
$0 $0 $0
ELIZABETH CRUTSINGER-PERRY IMMEDIATE PAST CHAIR 1.50
Officer Director
$0 $0 $0
SARAH BRAUNSTEIN VICE CHAIR (FROM 6/2023) 1.50
Officer Director
$0 $0 $0
RICARDO FERNANDEZ VICE CHAIR (END 5/2023) 1.50
Officer Director
$0 $0 $0
DEBRA GUILBAULT SECRETARY 1.50
Officer Director
$0 $0 $0
JEREMY TURNER TREASURER 1.50
Officer Director
$0 $0 $0
VINCE AGUON DIRECTOR (FROM 3/2023) 1.00
Director
$0 $0 $0
MELVERTA BENDER DIRECTOR (END 5/2023) 1.00
Director
$0 $0 $0
KATHLEEN BRADY DIRECTOR (FROM 6/2023) 1.00
Director
$0 $0 $0
LARISA BRUNER DIRECTOR (FROM 6/2023) 1.00
Director
$0 $0 $0
SAMUEL BURGESS DIRECTOR 1.00
Director
$0 $0 $0
JACQUELYN CLYMORE DIRECTOR (END 5/2023) 1.00
Director
$0 $0 $0
ANDY DILLEHAY DIRECTOR (FROM 6/2023) 1.00
Director
$0 $0 $0
TOM DUNN DIRECTOR (FROM 6/2023) 1.00
Director
$0 $0 $0
JAMILA EALEY DIRECTOR (END 2/2023) 1.00
Director
$0 $0 $0
DAWN FUKUDA DIRECTOR 1.00
Director
$0 $0 $0
ANTHONY HANNAH DIRECTOR (FROM 6/2023) 1.00
Director
$0 $0 $0
MARIA JACKSON DIRECTOR (FROM 6/2023) 1.00
Director
$0 $0 $0
CHRISTINE JONES DIRECTOR 1.00
Director
$0 $0 $0
KATHRYN MACOMBER DIRECTOR (END 5/2023) 1.00
Director
$0 $0 $0
ALI MANSARAY DIRECTOR (END 5/2023) 1.00
Director
$0 $0 $0
RANDY MAYER DIRECTOR (END 5/2023) 1.00
Director
$0 $0 $0
FELENCIA MCGEE DIRECTOR (FROM 6/2023) 1.00
Director
$0 $0 $0
VONTRESE MCGHEE DIRECTOR 1.00
Director
$0 $0 $0
MARLENE MCNEESE DIRECTOR (END 5/2023) 1.00
Director
$0 $0 $0
LORLETTE MOIR DIRECTOR 1.00
Director
$0 $0 $0
ANDREA PEREZ DIRECTOR (FROM 6/2023) 1.00
Director
$0 $0 $0
THADDEUS PHAM DIRECTOR 1.00
Director
$0 $0 $0
MARISA RAMOS DIRECTOR 1.00
Director
$0 $0 $0
SCOTT STOKES DIRECTOR (FROM 6/23) 1.00
Director
$0 $0 $0
KIMBERLY TRUSS DIRECTOR (FROM 6/2023) 1.00
Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2025 No data No data No data No data
2024 No data No data No data No data
2023 $26,523,136 $25,983,603 $13,162,788 $539,533
2022 $18,000,771 $17,011,945 $12,367,221 $988,826
2021 $12,449,778 $11,208,549 $9,712,969 $1,241,229
2020 $9,262,445 $8,752,930 $6,990,379 $509,515
2019 $13,405,364 $13,073,457 $7,125,193 $331,907
2018 $13,795,987 $14,266,038 $3,185,839 $-470,051
Explore More Nonprofits
Top 100 Nonprofits in District of Columbia Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare NATIONAL ALLIANCE OF STATE AND TERRITORIAL AIDS DIRECTORSDBA NASTAD with other nonprofits in District of Columbia and across the country.